Post The Parker Institute for Cancer Immunotherapy Appoints Immunotherapy Expert John Connolly as Chief Scientific Officer
Post The Parker Institute for Cancer Immunotherapy Appoints Seasoned Health Care Leader Frederic Pla as Chief Operating Officer
Post The Parker Institute for Cancer Immunotherapy Awards More Than $1 Million to Four Early Career Investigators
Post Guardant Health and PICI Launch Research Collaboration To Study Connection Between Cancer Biomarkers and Immunotherapy Treatment Response
Post Biomarkers May Predict Better Immunotherapy Treatment Outcomes for Certain Patients with Pancreatic Cancer